McCaul applauds Texas Children's, Baylor development of COVID-19 vaccine

Jun 10, 2021
Press Release

Austin, TX – Congressman Michael McCaul (TX-10) released the following statement after Texas Children’s Hospital in Houston, TX announced the Phase III clinical trials for their COVID-19 vaccine candidate, developed in partnership with Baylor College of Medicine and Biological E Limited. The Government of India announced an advance purchase of 300 million doses of the vaccine. In the recent weeks, the country has experienced a severe spike in COVID-19 cases and deaths.

“Texas Children’s Hospital continues to lead in the research and development of treatments and cures to improve the overall health of the global community,” said McCaul. “From addressing HIV/AIDS globally and pediatric cancer in sub-Saharan Africa to supporting the development of a new COVID-19 vaccine, they continue to excel in their efforts. I applaud the dedicated health care professionals who made this life-saving effort possible and am proud to be from a state that is leading the charge.”